Daniel D. Von Hoff
0000-0003-4723-7681
Publication & Citation Trends
Publications
0 total
A phase-Ib study of TRK-950 combined with anticancer treatment regimens in patients with gastric and gastro-esophageal junction (GEJ) cancer.
Cited by 1
Semantic Scholar
Utilization of a novel 3D radiologic scoring method to define therapeutic response and surgical candidacy OA
Cited by 0
Semantic Scholar
Can Imaging Using Radiomics and Fat Fraction Analysis Detect Early Tissue Changes on Historical CT Scans in the Regions of the Pancreas Gland That Subsequently Develop Adenocarcinoma? OA
Cited by 4
Semantic Scholar
Small molecule targeting of transcription-replication conflict for selective chemotherapy OA
Cited by 46
Semantic Scholar
Using tumor growth rate to inform treatment efficacy in pancreatic adenocarcinoma: From the metastatic to the neoadjuvant setting.
Cited by 0
Semantic Scholar
Abstract CT549: Randomized Phase II trial of two different nutritional approaches for patients receiving treatment for their advanced pancreatic cancer
Cited by 0
Semantic Scholar
NP-G2-044, a First-in-Class Fascin Inhibitor, Inhibits Growth and Metastasis of Gynecologic Cancers OA
Cited by 2
Semantic Scholar
Randomized phase II trial of two different nutritional approaches for patients receiving treatment for their advanced pancreatic cancer.
Cited by 1
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(371)
Cancer Genomics and Diagnostics
(235)
Cancer Treatment and Pharmacology
(172)
Cancer therapeutics and mechanisms
(132)
Epigenetics and DNA Methylation
(115)
Affiliations
United States Army Medical Command
Ulsan College
Roche (Switzerland)
Scottsdale Community College
University of Maryland, Baltimore